Has AI Changed the Course of Drug Development? Three Years Later

Almost three years ago I wrote Has AI Changed the Course of Drug Development? . The post was cautiously skeptical. AlphaFold was the headline. BenevolentAI had just flopped a Phase 2a in atopic dermatitis. Verge Genomics&rsquo; VRG50635 was about to enter the clinic. I argued that data quality was the real bottleneck, not algorithms. Time to revisit that. I now lead epigenomics bioinformatics at…